These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 14725154)
1. Lantus: a new insulin. Keresztes PA; Brick K Medsurg Nurs; 2003 Dec; 12(6):408-10. PubMed ID: 14725154 [No Abstract] [Full Text] [Related]
2. Lantus reduces blood glucose levels, less hypoglycemia in treatment of type 2 diabetes. Walczak IM Diabetes Technol Ther; 2002; 4(5):735-6. PubMed ID: 12458566 [No Abstract] [Full Text] [Related]
3. New strategies for the management of diabetes: insulin analogs and premixed insulin analogs. Diabetes Educ; 2003 Jun; Suppl():4-14; quiz 15-18. PubMed ID: 14725305 [No Abstract] [Full Text] [Related]
4. [Documented advantages of insulin Lantus when compared with NPH insulin]. Frid A Lakartidningen; 2004 Sep; 101(39):3014. PubMed ID: 15493644 [No Abstract] [Full Text] [Related]
5. Insulin analogues: a step forward in the care in diabetes. Holt RI Diabetes Obes Metab; 2009 Jan; 11(1):1-4. PubMed ID: 19120430 [No Abstract] [Full Text] [Related]
6. [Insulin analogues--which dimension should be discussed?]. Verspohl EJ Med Monatsschr Pharm; 2006 Jun; 29(6):198-9. PubMed ID: 16792195 [No Abstract] [Full Text] [Related]
7. Insulin detemir (levemir), a new long-acting insulin. Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022 [TBL] [Abstract][Full Text] [Related]
8. More from PHARMAC on long-acting insulin analogues: insulin glargine now funded. Moodie P N Z Med J; 2006 Jun; 119(1236):U2040. PubMed ID: 16807582 [No Abstract] [Full Text] [Related]
9. [My quality of life has increased with Lantus]. Euler H Lakartidningen; 2004 Sep; 101(39):3015; discussion 3016. PubMed ID: 15493645 [No Abstract] [Full Text] [Related]
10. [Lantus is superior in BOT (basic oral therapy) to standard mixed insulin]. Krankenpfl J; 2004; 42(5-6):172. PubMed ID: 15527234 [No Abstract] [Full Text] [Related]
11. Comment and reply on: Relative efficacy/effectiveness and relative costs of treatment with insulin glargine and insulin detemir. Freemantle N; Stella P; Munro V Curr Med Res Opin; 2007 Aug; 23(8):1761-2; author reply 1762-4. PubMed ID: 17588305 [No Abstract] [Full Text] [Related]
16. [Therapy with insulin]. Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R Acta Med Austriaca; 2004; 31(5):164-5. PubMed ID: 15747988 [TBL] [Abstract][Full Text] [Related]
17. Clinical therapeutics. Realising the value of modern insulins: reaching further with rapid-acting insulin analogues. XIX World Diabetes Congress, Cape Town, South Africa, December 3, 2006. Forward. Heise T Clin Ther; 2007; 29 Suppl D():S133-4. PubMed ID: 18504874 [No Abstract] [Full Text] [Related]
18. An update on the long-acting insulin analogue glargine. Thisted H; Johnsen SP; Rungby J Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic characteristics and clinical indication of insulin analogues]. Matsuhisa M; Kuroda A Nihon Rinsho; 2012 May; 70 Suppl 3():658-63. PubMed ID: 22768594 [No Abstract] [Full Text] [Related]
20. [Relationship between diabetology and oncology. Cancer alarm initially without practical consequences]. Aumiller J MMW Fortschr Med; 2009 Oct; 151(42):16, 18. PubMed ID: 19938774 [No Abstract] [Full Text] [Related] [Next] [New Search]